Prostate Cancer Trial, Recruiting NCT05241236 Sponsor: Urological Research Network, LLC Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT05241236
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men aged 50 to 65 who have been clinically diagnosed with low or intermediate risk prostate cancer, where fewer than half of the tissue samples taken from each side of the prostate tested positive for cancer
  • Men aged over 65 who have been clinically diagnosed with prostate cancer, where fewer than half of the tissue samples taken from each side of the prostate tested positive for cancer
  • People whose cancer has not spread beyond the outer layer of the prostate
  • People whose cancer has not spread to the seminal vesicles (small glands near the prostate)
  • People whose cancer has not spread to nearby lymph nodes or other parts of the body
  • People who have had a specific type of prostate scan (called a multiparametric MRI) either before their biopsy or more than 10 weeks after their biopsy
  • People who are being treated with a procedure called cryotherapy (which uses freezing temperatures to treat the prostate)
  • People whose treatment plan uses a combined imaging approach that matches MRI scans with prostate ultrasound images

Who may not be able to join:

  • People who have previously had surgery to treat prostate cancer
  • People who are not fully active and independent in daily life, based on a standard medical performance scale (confirm with trial site)
  • People who have a condition affecting their mental capacity

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: FERNANDO J BIANCO, MD, UROLOGICAL RESEARCH NETWORK

Phone: 305-515-9887

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Urological Research Network, LLC
Registry
ClinicalTrials.gov
Start date
15 November 2020
Est. completion
1 November 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Primary Oncological Control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov